be expected if no codiversification had occurred ( fig. S4 ; P = 1.79 × 10 −11
; t = -6.73, df = 88). Although mammalian gut microbes are highly adapted to life in this body habitat, and many lineages are extremely rare outside of it (29) , they appear to be fairly promiscuous between hosts. This could account for the spectacular success of mammals and herbivores in particular: Acquiring a gut microbiota was not a constraint, and morphological and behavioral adaptations were likely far more restrictive. One implication of this work is that the tolerance of the immune system to gut microbes is a basal trait in mammal evolution.
The global success of humans is based in part on our ability to control the variety and amount of food available using agriculture and cookery. These capabilities have not appreciably affected the major bacterial lineages that constitute our gut microbiota: As noted above, fecal samples from unrelated healthy human samples cluster with other omnivores (Fig. 1 and fig. S2 ), with interpersonal differences (UniFrac distances) being significantly smaller than the distances between humans and all other mammalian species (G = -47.7, P < 0.005, n = 106). Although our interpersonal differences appear to be smaller than interspecies differences among mammals, deeper sampling and analysis will be required to circumscribe the gut microbial diversity inherent to humans. This is one of the early goals of the recently initiated international human microbiome project (1). T ype IV secretion systems (TFSSs) are molecular machines used by Gram-negative bacteria for protein transfer into recipient cells (1) . Many bacterial pathogens and endosymbionts use TFSSs to regulate host processes important for survival and replication (2) , and several of these organisms have a large number of genes encoding proteins with multiple ankyrin repeat homology domains (ARHDs) (3-7). Infrequently encountered in bacterial proteins but common in eukaryotic proteins, ARHDs form molecular scaffolds that mediate protein-protein interactions (8) . An Anaplasma phagocytolyticum protein containing multiple ARHDs called AnkA (9) and several ARHD proteins in strains of Wolbachia (10, 11) have been proposed to be delivered into host cells by a TFSS (12) ; however, whether Ank proteins are bona fide TFSS effectors has not been established.
Legionella pneumophila and Coxiella burnetii are both intracellular pathogens that encode several proteins containing ARHDs and a TFSS called Dot/Icm (5-7). To test whether ARHD proteins are TFSS substrates, we measured host cell translocation of four L. pneumophila Ank proteins fused to a calmodulin-dependent adenylate cyclase reporter (Cya), using the L. pneumophila effector RalF as a positive control (13, 14) . These four Ank proteins were delivered into mammalian cells as indicated by a >10-fold increase in adenosine 3′,5′-monophosphate (cAMP) following infection (Fig. 1A) . No cAMP increase was observed when the Cya-Ank proteins were produced in the L. pneumophila ∆dotA mutant lacking a functional TFSS, which indicates that the Dot/Icm system is required for Ank protein delivery into host cells. Thirteen different C. burnetii proteins with ARHDs were tested for translocation with the Cya assay. Genetic ma-nipulation of the obligate intracellular pathogen C. burnetii is not currently possible, but the C. burnetii and L. pneumophila Dot/Icm systems are functionally similar (15, 16) , which suggests that L. pneumophila will deliver C. burnetii Dot/Icm substrates into host cells. C. burnetii AnkA, AnkB, AnkF, and AnkG fusion proteins were efficiently translocated into host cells by a process requiring the L. pneumophila Dot/Icm system (Fig. 1B) . The AnkE, AnkH, AnkI, and AnkM proteins were delivered less efficiently (Fig. 1B) . Specific Ank-encoding RNA transcripts were expressed during C. burnetii infection (Fig. 1C) , which suggests that protein products should be available for delivery into host cells by the C. burnetii Dot/Icm system. An antibody generated against AnkF confirmed that this protein was secreted during C. burnetii infection of mammalian cells (Fig.  1D) , whereas the C. burnetii translation factor EF-Ts was not and remained associated with bacteria in the pellet. The amount of secreted AnkF diminished over time after treatment with the bacterial protein synthesis inhibitor chloramphenicol, which did not measurably affect levels of AnkF associated with bacterial cells (Fig. 1D) . The short half-life of secreted AnkF revealed by chloramphenicol treatment could be the result of proteasome-mediated degradation if this protein was translocated into the host cytosol. Indeed, inhibition of the host proteasome with MG132 prevented degradation of secreted AnkF in the chloramphenicoltreated cells (Fig. 1E) , which indicated that secreted AnkF was located in the host cytosol. where at least 50 different vacuoles in different cells were assessed. Asterisks represent data that showed significant difference from control (wild type, 0.5 hour) in an unpaired Student's t test. (B to D) The same assay described in (A) was conducted to examine the effects resulting from disrupting secretory transport using BFA (C), disrupting microtubules using nocodazole (C), or addition of both BFA and nocodazole (D).
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Thus, multiple C. burnetii Ank proteins are substrates of the Dot/Icm system, and AnkF is delivered into host cells during C. burnetii infection.
The four translocated L. pneumophila Anks were fused to green fluorescent protein (GFP) and ectopically produced in mammalian cells to address whether these proteins have effector functions. Each of the four Ank proteins showed a different pattern of subcellular localization in mammalian cells, which suggested that these proteins have different targets and distinct functions ( Fig. 2A) . Extensive fragmentation of the Golgi apparatus was observed in cells producing GFPAnkX, which correlated with a significant defect in the release of secreted alkaline phosphatase (AP) into the tissue culture medium (Fig. 2, B  and D) . GFP-AnkX deletion derivatives revealed that ARHDs and the amino-terminal region of AnkX were both required for disrupting secretory transport (Fig. 2, C and D) .
Effectors translocated by the Dot/Icm system have predicted roles in blocking fusion of the L. pneumophila-containing vacuole with late endosomes and in promoting vacuole fusion with endoplasmic reticulum (ER)-derived vesicles (17) . To determine whether AnkX is an effector that controls membrane transport, we further investigated the process of AnkX-mediated dispersion of the Golgi apparatus in mammalian cells by time-lapse microscopy. AnkX protein was microinjected into cells producing the resident Golgi enzyme N-acetylgalactosaminyltransferase II fused to yellow fluorescent protein (GalNAc-T2-YFP). Compared with control cells treated with brefeldin A (BFA) (movie S1), which stimulated retrograde transport of Golgi membranes and cargo back to the ER, microinjected AnkX protein resulted in dispersal of GalNAc-T2-YFP into peripheral vesicles formed during Golgi fragmentation, with no apparent delivery back to the ER (Fig. 3A and movie S2) . Thus, the AnkX activity more closely mimicked fragmentation of the Golgi that occurs during mitosis (movie S2, cells marked "M"), when transport of vesicles from the ER to the Golgi is blocked.
The CopI and CopII coat proteins control initial events important for ER vesicle transport to the Golgi apparatus and colocalize on early secretory vesicles (18) . CopI and CopII staining revealed no defects in the morphology of vesicles at ER exit sites in AnkX-injected cells (Fig. 3B) , which suggests that AnkX does not affect this early stage in vesicle production from the ER. Interfering with vesicle production from ER exit sites by production of the guanosine diphosphate (GDP)-locked Arf1T31N protein blocked AP secretion and reduced L. pneumophila replication in mammalian cells (Fig. 3C) . AnkX production blocked AP secretion, but did not interfere with L. pneumophila replication (Fig. 3C) . Thus, AnkX disrupts secretory transport after vesicles have exited the ER.
To address whether AnkX specifically prevented the transport of early secretory vesicles, we followed endocytic transport of transferrin in cells microinjected with AnkX protein (movie S3). In neighboring cells that were not injected with AnkX, fluorescently labeled transferrin was internalized and transported to perinuclear sorting compartments (Fig. 3D) . In AnkX-injected cells, however, transferrin remained in peripheral endosomes that enlarged over time (movie S3 and Fig. 3D ). The effects of AnkX resembled what occurs when cells are treated with the drug nocodazole (19) (20) (21) , which depolymerizes microtubules. However, tubulin staining in cells microinjected with AnkX revealed no morphological defects in microtubules (Fig. 3E) , which indicates that AnkX interfered with microtubuledependent transport of vesicles without affecting the organization of the microtubule network.
Because microtubule-dependent transport is important for early to late endosome maturation (19) (20) (21) , trafficking of wild-type L. pneumophila was compared with that of isogenic ∆dotA and ∆ankX mutants to determine whether AnkX was important for L. pneumophila evasion of endocytic maturation. The majority of vacuoles containing wild-type L. pneumophila evaded fusion with lysosomal-associated membrane protein (LAMP1)-positive late endosomes at 30 min and 2 hours post infection, whereas vacuoles containing the L. pneumophila ∆dotA mutant acquired LAMP1 within the first 30 min of infection (Fig.  4A) . Most vacuoles containing the L. pneumophila ∆ankX mutant were LAMP1-negative at 30 min (Fig. 4A) ; however, there was a significant increase at 2 hours in the number of LAMP1-positive vacuoles containing the ∆ankX mutant. When remodeling of the L. pneumophila-containing vacuole by ER-derived vesicles was prevented by treating cells with BFA, there was a significant increase in the number of LAMP1-positive vacuoles containing L. pneumophila ∆ankX mutants compared with the wild type at 30 min post infection (Fig. 4B) . The defect in avoiding LAMP1 acquisition for vacuoles containing the ∆ankX mutant was suppressed when the microtubule network was destabilized by nocodazole treatment (Fig. 4, C and D) . By contrast, vacuoles containing the L. pneumophila ∆dotA mutant acquired LAMP1 rapidly in nocodazoletreated cells. Thus, microtubule depolymerization had a specific effect that restored the ability of the ∆ankX mutant to efficiently avoid endocytic maturation, which indicates that interfering with microtubule-dependent vesicle transport mimics a virulence activity mediated by the AnkX protein during infection.
The L. pneumophila and C. burnetii Ank proteins represent a large and diverse family of proteins containing ARHDs that we determined to be translocated into eukaryotic cells by pathogen-associated TFSSs. As seen in eukaryotic proteins, the prediction is that these bacterial proteins will have diverse cellular functions that are achieved by targeting different host factors through ARHD-dependent interactions. Finding that the L. pneumophila AnkX protein interferes with microtubule-dependent vesicular transport demonstrates that Ank proteins have effector functions. In addition to preventing endocytic maturation of the pathogen-occupied vacuole, AnkX interfered with transport of ER-derived vesicles generated at peripheral ER exit sites, an activity that will facilitate recruitment of early secretory vesicles to the vacuole and aid in construction of the specialized organelle that supports L. pneumophila replication (fig. S1 ).
